Home

JOHN P BILBREY

CIK 1268386 · Chairman, President and CEO · last filed 2026-07-07

JOHN P BILBREY is a Chairman, President and CEO who has filed 259 SEC Form 4 insider transactions across 8 companies since 2007. The most recent filing shows the insider disposed of $2.0M of OLPX on Jul 7, 2026. Across all open-market trades the lifetime net is −$39.7M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $41.0M across reported positions. 48 SEC filings were submitted jointly with CO HERSHEY.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$40.99M

Companies

8

Total Filings

259

Lifetime Open-Market Net

-$39.72M

Filer Profile

Reported Address
C/O TAPESTRY, INC.
10 HUDSON YARDS
NEW YORK, NY 10001
Related Filers
CO HERSHEY — 48 joint filings, latest 2018-04-03
Elanco Animal Health Inc — 36 joint filings, latest 2024-12-03
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
OLAPLEX HOLDINGS, INC. (OLPX) Delisted Director 0 $2.07 $0 $661.0K 8 2026-07-07
CL Director 44,948 $87.00 $3.91M -$1.75M 62 2026-07-02
ELAN Director 120,122 $23.00 $2.76M $351.1K 6 2024-12-03
TPR Director 47,846 $117.11 $5.60M $448.2K 9 2024-11-15
CPB Director 1,797 $21.36 $38.4K $0 16 2023-09-29
Elanco Animal Health Inc (ELAT) Delisted Director 81,579 $21.32 $1.74M $646.0K 28 2023-01-03
HSY Director 162,491 $170.42 $27.69M -$40.08M 45 2018-04-03
MKC.V Director 19,045 $51.85 $987.5K $0 83 2015-04-23

Recent Filings

259 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-07-07 OLAPLEX HOLDINGS, INC. (OLPX) Delisted Disp (D) −958,439 -$1.97M EDGAR
2026-07-02 CL Grant (A) +265 $23.7K EDGAR
2026-05-13 CL Grant (A) +2,075 $0 EDGAR
2026-04-03 CL Grant (A) +266 $23.7K EDGAR
2026-01-06 CL Grant (A) +301 $23.7K EDGAR
2025-10-03 CL Grant (A) +289 $23.7K EDGAR
2025-08-14 OLAPLEX HOLDINGS, INC. (OLPX) Delisted Grant (A) +294,118 $0 EDGAR
2025-07-02 CL Grant (A) +264 $23.7K EDGAR
2025-05-14 CL Grant (A) +2,019 $0 EDGAR
2025-04-03 CL Grant (A) +231 $21.2K EDGAR
Showing 1–10 of 259
Page 1 of 26
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.